KIOmed Pharma Overview

  • Founded

  • 2012

Founded
  • Status

  • Private

  • Employees

  • 32

Employees
  • Latest Deal Type

  • PE Growth

  • Financing Rounds

  • 6

  • Investments

  • 1

KIOmed Pharma General Information

Description

Manufacturer and distributor of therapeutic devices intended to treat patients who suffer from high-impact pathologies. The company's devices and implants integrate proprietary animal-free chitosan-based technologies in the field of ophthalmology, hemostasis, biosurgery, tissue engineering and regenerative medicine, enabling healthcare providers to cure their patients.

Contact Information

Website
www.kiomedpharma.com
Formerly Known As
Synolyne Pharma
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Rue Haute Claire 4
  • 4040 Herstal
  • Belgium
+32 04 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KIOmed Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KIOmed Pharma‘s full profile, request access.

Request a free trial

KIOmed Pharma Patents

  • 37

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

KIOmed Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4132980-A1 Chitosan-based beads, and preparation, compositions and uses thereof Pending 23-Nov-2020 000000000
FR-3116534-A1 Chitosan-based beads, preparation, compositions and applications Pending 23-Nov-2020 00000000 0
US-20230066712-A1 Chitosan-based beads, and preparation, compositions and uses thereof Pending 23-Nov-2020 00000000
EP-3976663-A1 Chitosan and applications thereof Pending 24-May-2019 0000000000
FR-3096260-B1 Chitosan and its applications Active 24-May-2019 C08B37/003
To view KIOmed Pharma’s complete patent history, request access »

KIOmed Pharma Executive Team (10)

Name Title Board Seat Contact Info
Houtai Choumane Ph.D Chief Executive Officer, Managing Director & Board Member
Quentin Hansenne Chief Financial Officer
Mathias Schifflers Chief Medical & Development Officer
Sandrine Gautier Ph.D Chief Development - Ophthalmology
Bertrand Duquesne Chief Operations Officer
You’re viewing 5 of 10 executive team members. Get the full list »

KIOmed Pharma Board Members (8)

Name Representing Role Since
000000 000000 Self Board Member 000 0000
00000000 0000000 0 Self Board Member 000 0000
0000ç000 0000000 Self Co-Founder & Executive Chairman 000 0000
000000000 0000000 Noshaq Board Member 000 0000
0000 00000 00 0000 Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

KIOmed Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KIOmed Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KIOmed Pharma‘s full profile, request access.

Request a free trial

KIOmed Pharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2014 000000 00 Food Products
To view KIOmed Pharma’s complete acquisitions history, request access »